<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-11T08:17:17Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.11553" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.11553</identifier>
    <datestamp>2024-09-25T17:26:04Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2024-09-25</dc:date>
  <dc:title>A Novel Attenuated and Marker M. bovis-BoHV-1 Combined Vaccine Provides Broad Protection Against Diverse Bovine Herpesvirus Type 1 Genotypes</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.11553</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Bovine herpesvirus 1 (BoHV-1) and Mycoplasma bovis&amp;nbsp;are major pathogens causing significant respiratory disease and reproductive issues in cattle. In our previous&amp;nbsp;study, we&amp;nbsp;prepared a M. bovis-BoHV-1 combined vaccine and evaluated its safety and efficacy. In the current study, the combined&amp;nbsp;vaccine was then compared to an inactivated BoHV-1 vaccine in protecting cattle against&amp;nbsp;BoHV-1&amp;nbsp;challenge. Cattle were divided into three groups: the M. bovis-BoHV-1 combined vaccine, the inactivated vaccine, and a non-immune challenge group. The groups were challenged with either the BoHV-1 1.1a or&amp;nbsp;1.2b&amp;nbsp;strains, and virus shedding was measured using RT-PCR. The results showed that&amp;nbsp;the combined&amp;nbsp;vaccine group was&amp;nbsp;able to induce a higher level of humoral immune response compared to the inactivated vaccine group, and it induced a high degree of expression of cytokines, B cells and T cell-associated signaling pathways. Both the combined&amp;nbsp;vaccine group and the inactivated vaccine group had significantly lower titers and shorter duration of virus shedding compared to the non-immune challenge group, for both BoHV-1 strain challenges. Specifically, the combined&amp;nbsp;vaccine group&amp;nbsp;had about 2 titers&amp;nbsp;reduction in peak virus titers and a 6-8&amp;nbsp;day earlier clearance of virus shedding compared to the non-immune challenge&amp;nbsp;group. Notably, the combined&amp;nbsp;vaccine group demonstrated slightly better performance in limiting virus shedding of the different BoHV-1 subtypes compared to the inactivated vaccine group, indicating the combined&amp;nbsp;vaccine may provide better cross-protection.&amp;nbsp;These findings highlight the protective efficacy of these vaccines and provide important insights for effective disease control strategies in cattle herds.</dc:description>
  <dc:subject>BoHV-1; genotype; combined vaccine; inactivated vaccine; cross-protection</dc:subject>
  <dc:creator>Sen Zhang</dc:creator>
  <dc:creator>Guoxing Liu</dc:creator>
  <dc:creator>Zhijie Xiang</dc:creator>
  <dc:creator>Jianguo Chen</dc:creator>
  <dc:creator>Aizhen Guo</dc:creator>
  <dc:creator>Yingyu Chen</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>